TNM staging and treatment intent in lung cancer
TNM staging (tumour size, node involvement, metastasis) describes how far a lung cancer has spread, guiding whether treatment aims to cure (radical) or to relieve symptoms and prolong life (palliative).
Remember
Establish the TNM stage before choosing the intent of treatment: early-stage lung cancer can be treated radically, whereas cancer that has spread to distant organs is stage IV and is more likely to be managed with palliative intent.
Staging shows how far the cancer has spread. Lung cancer is staged with the TNM system. T covers the size and local invasion of the tumour, N covers spread to nearby lymph nodes, and M covers distant metastases (spread to other organs). The stage comes from imaging, such as a staging chest CT, PET-CT (a scan that picks out areas of high sugar uptake, which are typical of cancer) or MRI, together with tissue sampling. The cell type comes from the biopsy, which is a separate step from staging.
Stage and fitness decide the intent of treatment. Radical treatment aims at cure, and it is only realistic when the cancer is confined to the lung and nearby nodes. Surgery is the main curative treatment for early-stage non-small cell lung cancer (a cell type of lung cancer), and radical radiotherapy (a high dose of radiation aimed at the tumour) is used for localised disease in people who cannot or do not want surgery. Early-stage disease is more likely to respond to radical therapy.
Distant metastases mean M1 disease, which makes the lung cancer stage IV. Removing or irradiating the lung tumour alone cannot cure the cancer, because cancer cells are already established elsewhere in the body. Treatment is then systemic therapy (drugs carried in the blood that reach cancer anywhere in the body) with palliative intent, and palliative radiotherapy and supportive care sit alongside it. Palliative intent means aiming to control the cancer and prolong survival, while relieving symptoms and protecting quality of life, rather than to cure.
General fitness, called performance status, helps decide whether radical treatment can be tolerated. The subtype of the tumour, meaning its cell type (for example small cell or non-small cell), helps choose the drugs, while the stage and fitness decide the intent of treatment.
Key facts
- TNM stands for
- tumour size, node involvement and distant metastases.
- Purpose of staging
- it guides treatment options and gives prognostic information (an estimate of the likely outcome).
- Early stage
- radical treatment, such as surgery or radical radiotherapy, becomes possible.
- Stage IV
- the cancer has spread to distant organs, so management centres on palliation (relieving symptoms and prolonging life) with systemic therapy and supportive care.
- Staging versus biopsy
- staging describes how far the cancer has spread, whereas the biopsy gives the cell type.
- What sets the intent
- the stage and fitness, while the subtype helps choose the drugs.
Exam traps
- Surgery is not the standard treatment for stage IV lung cancer: once distant metastases are present, removing the tumour in the lung does not remove the cancer, so treatment is systemic.
- A large tumour does not by itself make lung cancer palliative, because large tumours can still be treated with radical intent when there are no distant metastases.
- TNM stage does not come from the cell type seen on biopsy: it describes the extent of the cancer and depends on imaging such as CT or PET-CT, while the cell type comes from the biopsy.
Read the full notes
Tested in 6 SimpleMed+ questions
Practice it in Respiratory System, with the answer and a full explanation after every question.
Practice these questions